CPP-109 vigabatrin
CPP-02001
Phase 2 small_molecule terminated
Quick answer
CPP-109 vigabatrin for Methamphetamine Dependence is a Phase 2 program (small_molecule) at CATALYST PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- CATALYST PHARMACEUTICALS, INC.
- Indication
- Methamphetamine Dependence
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- terminated